Profile data is unavailable for this security.
About the company
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
- Revenue in USD (TTM)6.55bn
- Net income in USD-530.20m
- Incorporated2017
- Employees13.50k
- LocationAvantor IncBuilding One100 W Matsonford Rd Ste 200RADNOR 19087United StatesUSA
- Phone+1 (610) 386-1700
- Fax+1 (302) 636-5454
- Websitehttps://www.avantorsciences.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICU Medical Inc | 2.23bn | 732.00k | 3.63bn | 13.00k | 5,955.83 | 1.71 | 17.74 | 1.63 | 0.0247 | 0.0247 | 90.50 | 86.03 | 0.5406 | 2.35 | 12.28 | 171,635.50 | 0.0465 | -0.6518 | 0.0534 | -0.7376 | 36.84 | 34.16 | 0.0861 | -1.11 | 1.15 | 1.70 | 0.378 | -- | -6.33 | 11.91 | 100.62 | -61.53 | -0.6816 | -- |
| LivaNova PLC | 1.39bn | -242.47m | 3.84bn | 3.30k | -- | 3.20 | -- | 2.77 | -4.47 | -4.47 | 25.37 | 21.96 | 0.543 | 2.84 | 6.79 | 420,622.10 | -9.48 | -3.21 | -12.39 | -3.97 | 68.04 | 68.27 | -17.46 | -6.55 | 1.16 | 3.67 | 0.2389 | -- | 10.74 | 8.24 | -483.45 | -- | 18.27 | -- |
| iRhythm Holdings, Inc | 747.14m | -44.55m | 4.15bn | 2.40k | -- | 27.16 | -- | 5.56 | -1.41 | -1.41 | 23.35 | 4.73 | 0.7657 | 12.33 | 9.60 | 311,307.50 | -4.57 | -16.40 | -5.28 | -19.65 | 70.57 | 68.67 | -5.96 | -19.44 | 4.48 | -- | 0.8096 | -- | 26.24 | 23.02 | 60.67 | -- | 27.88 | -- |
| Merit Medical Systems Inc | 1.52bn | 128.49m | 4.55bn | 7.50k | 35.99 | 2.87 | 17.85 | 3.00 | 2.13 | 2.13 | 25.07 | 26.66 | 0.594 | 2.43 | 7.70 | 202,120.80 | 5.03 | 4.56 | 5.53 | 5.10 | 48.70 | 46.73 | 8.48 | 7.34 | 2.95 | 16.77 | 0.3166 | 0.00 | 11.75 | 9.48 | 6.76 | -- | 11.48 | -- |
| Stevanato Group SpA | 1.37bn | 164.31m | 4.57bn | 5.52k | 25.07 | 2.45 | 17.44 | 3.34 | 0.602 | 0.602 | 5.01 | 6.16 | 0.5058 | 2.95 | 2.65 | 247,752.80 | 6.08 | 8.02 | 7.63 | 10.94 | 29.27 | 31.01 | 12.01 | 13.24 | 1.30 | 30.00 | 0.2386 | 6.82 | 1.72 | 15.53 | -19.13 | 24.61 | 33.52 | -- |
| Envista Holdings Corp | 2.72bn | 47.00m | 4.82bn | 12.00k | 107.07 | 1.55 | 29.60 | 1.77 | 0.275 | 0.275 | 16.10 | 18.96 | 0.4931 | 4.62 | 6.86 | 226,625.00 | 0.8523 | -2.14 | 1.01 | -2.58 | 55.02 | 56.70 | 1.73 | -5.21 | 2.04 | 6.70 | 0.318 | -- | 8.32 | 7.11 | 104.20 | 2.03 | -1.03 | -- |
| Lantheus Holdings Inc | 1.54bn | 233.56m | 4.93bn | 1.19k | 22.69 | 4.52 | 16.23 | 3.20 | 3.36 | 3.36 | 22.33 | 16.87 | 0.7328 | 9.04 | 4.53 | 1,292,212.00 | 11.10 | 11.26 | 12.85 | 12.98 | 61.10 | 61.61 | 15.15 | 14.47 | 2.51 | -- | 0.3432 | 0.00 | 0.5019 | 35.35 | -25.25 | -- | 23.67 | -- |
| TransMedics Group Inc | 605.49m | 188.99m | 5.04bn | 898.00 | 30.88 | 10.65 | 23.31 | 8.33 | 4.76 | 4.79 | 14.94 | 13.81 | 0.6467 | 5.09 | 6.65 | 674,269.50 | 20.19 | 4.75 | 21.93 | 5.18 | 59.92 | 61.27 | 31.21 | 8.52 | 6.59 | 84.70 | 0.5199 | 0.00 | 37.13 | 88.21 | 436.58 | -- | 164.81 | -- |
| Teleflex Inc | 2.39bn | 58.53m | 5.43bn | 15.50k | 99.15 | 1.74 | 23.00 | 2.27 | 1.24 | -20.56 | 53.59 | 70.70 | 0.341 | 2.23 | 5.95 | 154,489.00 | 0.8335 | 3.12 | 0.9266 | 3.43 | 53.13 | 57.05 | 2.44 | 10.06 | 2.01 | 2.73 | 0.4581 | 28.48 | 17.25 | -4.72 | 2.34 | -29.49 | 0.9821 | 0.00 |
| Caris Life Sciences Inc | -100.00bn | -100.00bn | 5.84bn | -- | -- | 12.18 | -- | -- | -- | -- | -- | 1.70 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 9.36 | -- | 0.4404 | -- | 34.67 | -- | 18.22 | -- | -- | -- |
| Avantor Inc | 6.55bn | -530.20m | 6.01bn | 13.50k | -- | 1.08 | -- | 0.9171 | -0.7775 | -0.7775 | 9.62 | 8.16 | 0.5481 | 5.70 | 6.21 | 485,348.20 | -4.44 | 2.78 | -5.17 | 3.18 | 32.65 | 33.77 | -8.09 | 5.00 | 1.18 | 3.62 | 0.4149 | 0.00 | -3.41 | 0.4913 | -174.52 | -- | 15.90 | -- |
| Bruker Corp | 3.44bn | -22.50m | 6.06bn | 11.09k | -- | 2.47 | 30.44 | 1.76 | -0.1485 | -0.1485 | 22.63 | 16.15 | 0.5705 | 1.64 | 5.22 | 310,013.50 | -0.1212 | 5.07 | -0.1553 | 6.76 | 47.13 | 49.70 | -0.2124 | 7.56 | 0.8553 | 9.30 | 0.4268 | 13.19 | 2.08 | 11.57 | -119.89 | -- | 4.34 | 4.56 |
| Glaukos Corp | 507.44m | -187.69m | 7.03bn | 1.09k | -- | 10.62 | -- | 13.86 | -3.27 | -3.27 | 8.87 | 11.41 | 0.5432 | 1.84 | 5.99 | 463,840.90 | -20.09 | -12.56 | -22.19 | -13.55 | 77.97 | 76.60 | -36.99 | -34.64 | 4.06 | -- | 0.094 | -- | 32.33 | 17.67 | -28.23 | -- | 28.47 | -- |
| Repligen Corp | 738.26m | 48.89m | 7.04bn | 2.00k | 144.59 | 3.34 | 55.15 | 9.54 | 0.8643 | 0.8643 | 13.05 | 37.39 | 0.2555 | 2.23 | 5.04 | 369,128.00 | 1.69 | 2.88 | 1.77 | 3.20 | 52.65 | 53.58 | 6.62 | 10.73 | 7.12 | -- | 0.2047 | 0.00 | 16.36 | 15.05 | 291.64 | -3.99 | -0.4706 | -- |
| Bio Rad Laboratories Inc | 2.58bn | 759.90m | 7.49bn | 7.45k | 10.02 | 1.01 | 8.10 | 2.90 | 27.91 | 27.91 | 94.69 | 276.16 | 0.2591 | 1.65 | 5.66 | 346,738.30 | 7.62 | -1.69 | 8.02 | -1.77 | 52.01 | 54.52 | 29.42 | -8.08 | 4.19 | -- | 0.139 | -- | 0.6507 | 0.2935 | 141.20 | -27.58 | 7.74 | -- |
Data as of Mar 02 2026. Currency figures normalised to Avantor Inc's reporting currency: US Dollar USD
57.23%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Dodge & Coxas of 31 Dec 2025 | 117.07m | 17.17% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 59.71m | 8.76% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 53.52m | 7.85% |
| Barrow, Hanley, Mewhinney & Strauss LLCas of 31 Dec 2025 | 33.29m | 4.88% |
| T. Rowe Price Investment Management, Inc.as of 31 Dec 2025 | 32.13m | 4.71% |
| Wellington Management Co. LLPas of 31 Dec 2025 | 22.91m | 3.36% |
| Greenhaven Associates, Inc.as of 31 Dec 2025 | 20.50m | 3.01% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 20.21m | 2.96% |
| Invesco Advisers, Inc.as of 31 Dec 2025 | 15.73m | 2.31% |
| Clarkston Capital Partners LLCas of 31 Dec 2025 | 15.11m | 2.22% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
